This document covers laboratory chemical analysis of aseptically prepared products. The reasons for analysis are outlined in Section 2 of this document
The stability of several aseptically compounded ready to administer presentations of monoclonal antibody products and other biopharmaceuticals is presented.

Aseptic services

Accredited training for pharmacy staff within technical services

17 March 2023Pharmacy staff involved in the preparation of aseptically-prepared products should be suitably trained and accredited to assure a safe service

Dealing with out of specification (OOS) results: Part 1

20 January 2023This webinar will explore the approach to managing out of specification environmental monitoring results in pharmacy aseptic units

Assurance of aseptic preparation of medicines

13 January 2023Updated guidance from NHSE to reflect governance and visibility of the assurance and audit of unlicensed aseptic preparation

Understanding iQAAPS

13 January 2023An introduction to the iQAAPS system, with information on how to access the system, find training resources and support contacts

Choosing an injectable medicine for intrathecal administration

11 August 2022The intrathecal route is a high risk route of administration. It is essential to consider the properties of the medicinal product when assessing the risk

Morphine products: information for supporting intrathecal risk assessment

11 August 2022Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Search Aseptic services